# Multisystemic Complications and Rapid Decline in Anti‐MDA‐5 Positive Amyopathic Dermatomyositis: A Case Study

## TL;DR

This case study shows how a rare autoimmune disease can quickly cause severe health issues, emphasizing the importance of early diagnosis and treatment.

## Contribution

The case highlights the aggressive progression of anti-MDA-5 positive amyopathic dermatomyositis and the importance of timely immunosuppressive therapy.

## Key findings

- Anti-MDA-5 positive amyopathic dermatomyositis can rapidly lead to severe interstitial lung disease.
- Early diagnosis and comprehensive immunosuppressive therapy are crucial for improving outcomes in this condition.

## Abstract

Anti‐MDA‐5 positive amyopathic dermatomyositis (CADM) can lead to rapid multisystemic complications, including severe interstitial lung disease (ILD). This case, involving a 60‐year‐old female with worsening skin lesions and ILD, demonstrates the disease's aggressive nature, highlighting the need for early diagnosis and comprehensive immunosuppressive therapy to improve patient outcomes.